首页> 外国专利> COMPLEX PROFILE OF CELL ANTIGEN AND TARGET SIGNALING PROTEIN FOR ANALYSIS AND CLINICAL MANAGEMENT OF BLOOD CANCER

COMPLEX PROFILE OF CELL ANTIGEN AND TARGET SIGNALING PROTEIN FOR ANALYSIS AND CLINICAL MANAGEMENT OF BLOOD CANCER

机译:用于血液癌症分析和临床治疗的细胞抗原和靶标信号蛋白的复杂特征

摘要

PROBLEM TO BE SOLVED: To provide a method of preparing a complex marker profile of a sample derived of individuals with a suspected neoplastic pathological condition.;SOLUTION: A complex marker profile according to the invention enables to identify a subgroup of a neoplastic pathological condition and to predict a clinic course of individuals related to a prognosis and treatment. This method provides a useful tool for selecting a treatment for individuals suffered from the neoplastic pathological condition, including a method of determining a risk group, a method of predicting an increased risk of recurrence, a method of predicting an increased risk of development of second complication, a method of selecting of treatment for individuals, a method of determining a treatment effect of individuals, and a method of determining prognosis of individuals. In particular, this method discloses a method of preparing the complex marker profile which plays a role as prognosis indicators for predicting whether a course of the neoplastic pathological condition of individuals is progressive or indolent, resulting in being useful for managing patients and evaluating treatments to be used by clinicians.;COPYRIGHT: (C)2012,JPO&INPIT
机译:解决的问题:提供一种制备具有疑似肿瘤病理状况的个体的样品的复杂标志物谱的方法。解决方案:根据本发明的复杂标志物谱能够鉴定肿瘤病理学条件的亚组和预测与预后和治疗有关的个体的临床病程。该方法提供了用于为患有肿瘤性病理状况的个体选择治疗的有用工具,包括确定风险组的方法,预测复发风险增加的方法,预测第二并发症发生风险增加的方法。 ,针对个体的治疗选择方法,确定个体的治疗效果的方法以及确定个体的预后的方法。特别地,该方法公开了一种制备复杂标志物概况的方法,该复杂标志物概况起着预后指标的作用,该预后指标用于预测个体的肿瘤病理状况的病程是进行性的还是惰性的,从而对于治疗患者和评估待治疗的药物是有用的。临床医生使用。;版权所有:(C)2012,JPO&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号